MedTrace Logo

Safety and Performance Evaluation of the Nephronyx System for the Treatment of Patients With ADHF

NCT05759806 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2025-05-25

No results posted yet for this study

Summary

The objective of this interventional study is to evaluate the safety and functional performance of the Nephronyx System in patients with ADHF, presenting clinical signs of volume overload and compromised response to diuretics.

Conditions

  • Acute Decompensated Heart Failure

Interventions

DEVICE

Nephronyx system (Perfuser)

Temporary deployment of the Nephronyx system (Perfuser)

Sponsors & Collaborators

  • Nephronyx LTD

    lead INDUSTRY

Principal Investigators

  • Doron Aronson, MD · Rambam Health Care Campus

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-12-19
Primary Completion
2026-06-30
Completion
2026-07-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05759806 on ClinicalTrials.gov